Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R (2021) Cellular mechanisms of liver fibrosis. Front Pharmacol 12:671640. https://doi.org/10.3389/fphar.2021.671640
Article CAS PubMed PubMed Central Google Scholar
Arias M, Sauer-Lehnen S, Treptau J, Janoschek N, Theuerkauf I, Buettner R, Gressner AM, Weiskirchen R (2003) Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol 3:29. https://doi.org/10.1186/1471-230X-3-29
Article PubMed PubMed Central Google Scholar
Avrutsky MI, Troy CM (2021) Caspase-9: a multimodal therapeutic target with diverse cellular expression in human disease. Front Pharmacol 12:701301. https://doi.org/10.3389/fphar.2021.701301
Article CAS PubMed PubMed Central Google Scholar
Borkham-Kamphorst E, Drews F, Weiskirchen R (2011) Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation. Liver Int 31:656–665. https://doi.org/10.1111/j.1478-3231.2011.02495.x
Article CAS PubMed Google Scholar
Borkham-Kamphorst E, Huss S, Van de Leur E, Haas U, Weiskirchen R (2012a) Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis. Liver Int 32:1342–1353. https://doi.org/10.1111/j.1478-3231.2012.02837.x
Article CAS PubMed Google Scholar
Borkham-Kamphorst E, van Roeyen CR, Van de Leur E, Floege J, Weiskirchen R (2012b) CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC. J Cell Commun Signal 6(1):11–25. https://doi.org/10.1007/s12079-011-0141-3
Borkham-Kamphorst E, Schaffrath C, Van de Leur E, Haas U, Tihaa L, Meurer SK, Nevzorova YA, Liedtke C, Weiskirchen R (2014) The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling. Biochim Biophys Acta 1843:902–914. https://doi.org/10.1016/j.bbamcr.2014.01.023
Article CAS PubMed Google Scholar
Borkham-Kamphorst E, Steffen BT, Van de Leur E, Haas U, Tihaa L, Friedman SL, Weiskirchen R (2016a) CCN1/CYR61 overexpression in hepatic stellate cells induces ER stress-related apoptosis. Cell Signal 28:34–42. https://doi.org/10.1016/j.cellsig.2015.10.013
Article CAS PubMed Google Scholar
Borkham-Kamphorst E, Steffen BT, Van de Leur E, Tihaa L, Haas U, Woitok MM, Meurer SK, Weiskirchen R (2016b) Adenoviral CCN gene transfers induce in vitro and in vivo endoplasmic reticulum stress and unfolded protein response. Biochim Biophys Acta 1863(11):2604–2612. https://doi.org/10.1016/j.bbamcr.2016.07.006
Article CAS PubMed Google Scholar
Borkham-Kamphorst E, Steffen BT, van de Leur E, Haas U, Weiskirchen R (2018) Portal myofibroblasts are sensitive to CCN-mediated endoplasmic reticulum stress-related apoptosis with potential to attenuate biliary fibrogenesis. Cell Signal 51:72–85. https://doi.org/10.1016/j.cellsig.2018.07.005
Article CAS PubMed Google Scholar
Borkham-Kamphorst E, Haas U, Van de Leur E, Trevanich A, Weiskirchen R (2020) Chronic carbon tetrachloride applications induced hepatocyte apoptosis in Lipocalin 2 null mice through endoplasmic reticulum stress and unfolded protein response. Int J Mol Sci 21(15):5230. https://doi.org/10.3390/ijms21155230
Article CAS PubMed PubMed Central Google Scholar
Chen L, Brigstock DR (2017) Analysis of pathological activities of CCN proteins in fibrotic diseases: liver fibrosis. Methods Mol Biol 1489:445–463. https://doi.org/10.1007/978-1-4939-6430-7_37
Article CAS PubMed PubMed Central Google Scholar
Dhanasekaran DN, Reddy EP (2017) JNK-signaling: a multiplexing hub in programmed cell death. Genes Cancer 8(9–10):682–694. https://doi.org/10.18632/genesandcancer.155
Article CAS PubMed PubMed Central Google Scholar
Dudas J, Mansuroglu T, Batusic D, Saile B, Ramadori G (2007) Thy-1 is an in vivo and in vitro marker of liver myofibroblasts. Cell Tissue Res 329:503–514. https://doi.org/10.1007/s00441-007-0437-z
Article CAS PubMed Google Scholar
Fehrenbach H, Weiskirchen R, Kasper M, Gressner AM (2001) Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology 34:943–952. https://doi.org/10.1053/jhep.2001.287880.1002/hep.1840070411
Article CAS PubMed Google Scholar
Gray MR, Malmquist JA, Sullivan M, Blea M, Castellot JJ Jr (2007) CCN5 Expression in mammals. II. Adult rodent tissues. J Cell Commun Signal 1:145–158. https://doi.org/10.1007/s12079-007-0013-z
Article PubMed PubMed Central Google Scholar
Gressner OA, Lahme B, Demirci I, Gressner AM, Weiskirchen R (2007) Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 47:699–710. https://doi.org/10.1016/j.jhep.2007.05.015
Article CAS PubMed Google Scholar
Gressner OA, Lahme B, Siluschek M, Rehbein K, Weiskirchen R, Gressner AM (2009) Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes–but without modulating bone morphogenetic protein 7 signaling. Hepatology 49:2021–2030. https://doi.org/10.1002/hep.22850
Article CAS PubMed Google Scholar
Guyot C, Combe C, Balabaud C, Bioulac-Sage P, Desmoulière A (2007) Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices. J Hepatol 46:142–150. https://doi.org/10.1016/j.jhep.2006.08.013
Article CAS PubMed Google Scholar
Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: structure-function relationships. Trends Biochem Sci 33(10):461–473. https://doi.org/10.1016/j.tibs.2008.07.0062
Article CAS PubMed PubMed Central Google Scholar
Jia Q, Zhang Y, Xu B, Liao X, Bu Y, Xu Z, Duan X, Zhang Q (2021) Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironment. Aging (albany NY) 13(17):21216–21231. https://doi.org/10.18632/aging.203424
Article CAS PubMed Google Scholar
Jian YC, Wang JJ, Dong S, Hu JW, Hu LJ, Yang GM, Zheng YX, Xiong WJ (2014) Wnt-induced secreted protein 1/CCN4 in liver fibrosis both in vitro and in vivo. Clin Lab 60:29–35. https://doi.org/10.7754/clin.lab.2013.121035
Article CAS PubMed Google Scholar
Jones JA, Gray MR, Oliveira BE, Koch M, Castellot JJ Jr (2007) CCN5 expression in mammals: I. Embryonic and fetal tissues of mouse and human. J Cell Commun Signal 1:127–143. https://doi.org/10.1007/s12079-007-0012-0
Article PubMed PubMed Central Google Scholar
Karin D, Koyama Y, Brenner D, Kisseleva T (2016) The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis. Differentiation 92:84–92. https://doi.org/10.1016/j.diff.2016.07.001
Article CAS PubMed PubMed Central Google Scholar
Katsumata LW, Miyajima A, Itoh T (2017) Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury. Hepatol Commun 1:198–214. https://doi.org/10.1002/hep4.1023
Article CAS PubMed PubMed Central Google Scholar
Kim KH, Chen CC, Monzon RI, Lau LF (2013) Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 33:2078–2090. https://doi.org/10.1128/MCB.00049-13
Article CAS PubMed PubMed Central Google Scholar
Kubota S, Kawata K, Hattori T, Nishida T (2022) Molecular and genetic interactions between CCN2 and CCN3 behind their Yin-Yang collaboration. Int J Mol Sci 23(11):5887. https://doi.org/10.3390/ijms23115887
Article CAS PubMed PubMed Central Google Scholar
Lei L, Bruneau A, El Mourabit H, Guégan J, Folseraas T, Lemoinne S, Karlsen TH, Hoareau B, Morichon R, Gonzalez-Sanchez E, Goumard C, Ratziu V, Charbord P, Gautheron J, Tacke F, Jaffredo T, Cadoret A, Housset C (2022) Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis. Hepatology 76:1360–1375. https://doi.org/10.1002/hep.32456
Article CAS PubMed Google Scholar
Li X, Chen Y, Ye W, Tao X, Zhu J, Wu S, Lou L (2015) Blockade of CCN4 attenuates CCl4-induced liver fibrosis. Arch Med Sci 11:647–653. https://doi.org/10.5114/aoms.2015.52371
Article PubMed PubMed Central Google Scholar
Li ZQ, Wu WR, Zhao C, Zhao C, Zhang XL, Yang Z, Pan J, Si WK (2018) CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma. Int J Mol Med 41:1518–1528. https://doi.org/10.3892/ijmm.2017.3356
Article CAS PubMed Google Scholar
Li W, Liao X, Ning P, Cao Y, Zhang M, Bu Y, Lv J, Jia Q (2019) Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma. BMC Cancer 19(1):395. https://doi.org/10.1186/s12885-019-5603-7
Article PubMed PubMed Central Google Scholar
Maiers JL, Malhi H (2019) Endoplasmic reticulum stress in metabolic liver diseases and hepatic fibrosis. Semin Liver Dis 39:235–248. https://doi.org/10.1055/s-0039-1681032
留言 (0)